Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 145601-145650 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT02486900
Neurofeedback & Alcohol Dependence
NA
Completed
52 participants
Started: Sep 30, 2015 · Completed: Aug 31, 2018
1 condition
2 sponsors
1 location
NCT02508870
A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes
PHASE1
Completed
46 participants
Started: Sep 30, 2015 · Completed: Jun 10, 2019
1 condition
1 sponsor
15 locations
NCT02558491
Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM
NA
Completed
33 participants
Started: Sep 30, 2015 · Completed: Feb 28, 2017
1 condition
2 sponsors
1 location
NCT02847273
Peripheral Four-wavelength Near-infrared Spectroscopy Measurement: a Comparison Between EQUANOX and O3 in Cardiac Surgery
N/A
Completed
20 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2015
1 condition
1 sponsor
1 location
NCT02555098
A Bilateral Dispensing Clinical Trial of an Sapphire Lens Against Senofilcon A Toric for Astigmatism Lens
NA
Completed
23 participants
Started: Sep 30, 2015 · Completed: Apr 30, 2016
1 condition
1 sponsor
1 location
NCT02455011
Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus
PHASE1/PHASE2
Completed
75 participants
Started: Sep 30, 2015 · Completed: Feb 28, 2018
2 conditions
1 sponsor
3 locations
NCT02487199
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease
PHASE3
Completed
18 participants
Started: Sep 30, 2015 · Completed: Dec 5, 2016
1 condition
1 sponsor
0 locations
NCT02221453
Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide
PHASE2
Completed
3 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2016
1 condition
1 sponsor
1 location
NCT02449473
Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids
PHASE2
Completed
79 participants
Started: Sep 29, 2015 · Completed: Jun 21, 2017
1 condition
1 sponsor
15 locations
NCT02471144
Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis
PHASE3
Completed
162 participants
Started: Sep 29, 2015 · Completed: Mar 30, 2023
1 condition
1 sponsor
46 locations
NCT02513446
Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1026706 in Healthy Male Subjects
PHASE1
Completed
16 participants
Started: Sep 29, 2015 · Completed: Nov 20, 2015
1 condition
1 sponsor
1 location
NCT02550288
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
PHASE3
Completed
309 participants
Started: Sep 29, 2015 · Completed: May 30, 2016
1 condition
1 sponsor
0 locations
NCT02654977
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy
PHASE2
Completed
11 participants
Started: Sep 29, 2015 · Completed: Nov 14, 2019
3 conditions
1 sponsor
1 location
NCT02554266
Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries
N/A
Completed
371 participants
Started: Sep 29, 2015 · Completed: Nov 22, 2019
1 condition
1 sponsor
26 locations
NCT02691520
Epidemiology of Treatment Resistant Depression in Taiwan
N/A
Completed
8,356 participants
Started: Sep 29, 2015 · Completed: Feb 18, 2016
1 condition
2 sponsors
0 locations
NCT02443805
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
PHASE3
Completed
1,607 participants
Started: Sep 29, 2015 · Completed: Jun 25, 2018
2 conditions
1 sponsor
2 locations
NCT02565576
Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
PHASE2
Completed
44 participants
Started: Sep 29, 2015 · Completed: Dec 19, 2017
1 condition
1 sponsor
15 locations
NCT02548377
Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial
NA
Completed
60 participants
Started: Sep 29, 2015 · Completed: Feb 26, 2018
1 condition
1 sponsor
1 location
NCT02592447
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
NA
Completed
48 participants
Started: Sep 29, 2015 · Completed: Sep 2, 2021
1 condition
2 sponsors
1 location
NCT02465450
Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
PHASE2
Completed
85 participants
Started: Sep 29, 2015 · Completed: Dec 28, 2016
1 condition
1 sponsor
27 locations
NCT02408822
Drug-Eluting Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis (DEBAVAS)
NA
Completed
52 participants
Started: Sep 29, 2015 · Completed: Jun 15, 2023
1 condition
1 sponsor
3 locations
NCT02549417
Phase 3 Study of KHK7580
PHASE3
Completed
39 participants
Started: Sep 29, 2015 · Completed: Dec 22, 2016
1 condition
1 sponsor
1 location
NCT02540954
Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
PHASE3
Completed
336 participants
Started: Sep 29, 2015 · Completed: Jun 4, 2020
1 condition
1 sponsor
71 locations
NCT02501629
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
PHASE3
Completed
177 participants
Started: Sep 29, 2015 · Completed: Dec 4, 2017
3 conditions
1 sponsor
127 locations
NCT02452918
A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
PHASE4
Completed
17 participants
Started: Sep 29, 2015 · Completed: Jul 5, 2016
1 condition
1 sponsor
1 location
NCT04096651
Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy
NA
Completed
48 participants
Started: Sep 28, 2015 · Completed: Jul 12, 2018
1 condition
3 sponsors
0 locations
NCT02533375
Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
PHASE3
Completed
10 participants
Started: Sep 28, 2015 · Completed: Jul 20, 2017
3 conditions
1 sponsor
0 locations
NCT02549404
Phase 3 Study of KHK7580
PHASE3
Completed
137 participants
Started: Sep 28, 2015 · Completed: Dec 28, 2016
1 condition
1 sponsor
1 location
NCT02552953
A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers
PHASE1
Completed
60 participants
Started: Sep 28, 2015 · Completed: Aug 25, 2023
1 condition
1 sponsor
1 location
NCT02715700
Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)
PHASE1
Completed
14 participants
Started: Sep 28, 2015 · Completed: Aug 15, 2016
1 condition
1 sponsor
0 locations
NCT02561273
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
PHASE1/PHASE2
Completed
54 participants
Started: Sep 28, 2015 · Completed: Nov 1, 2020
10 conditions
2 sponsors
8 locations
NCT02487797
Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation
PHASE4
Completed
1,003 participants
Started: Sep 28, 2015 · Completed: Sep 28, 2020
1 condition
1 sponsor
1 location
NCT02452190
Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
PHASE3
Completed
468 participants
Started: Sep 28, 2015 · Completed: Jan 31, 2018
1 condition
2 sponsors
226 locations
NCT02510794
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
PHASE2
Completed
225 participants
Started: Sep 28, 2015 · Completed: Mar 28, 2019
1 condition
1 sponsor
50 locations
NCT02500446
Dolutegravir Impact on Residual Replication
PHASE4
Completed
40 participants
Started: Sep 28, 2015 · Completed: Sep 30, 2017
1 condition
3 sponsors
2 locations
NCT02576795
Gene Therapy Study in Severe Haemophilia A Patients (270-201)
PHASE1/PHASE2
Completed
15 participants
Started: Sep 28, 2015 · Completed: Feb 14, 2024
1 condition
1 sponsor
5 locations
NCT02476968
To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer
PHASE4
Completed
181 participants
Started: Sep 28, 2015 · Completed: Dec 17, 2021
1 condition
1 sponsor
58 locations
NCT03203746
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
PHASE1/PHASE2
Completed
24 participants
Started: Sep 28, 2015 · Completed: Dec 14, 2016
1 condition
1 sponsor
0 locations
NCT02565004
Clinical and Laboratory Analysis of Familial Cancer
N/A
Completed
19 participants
Started: Sep 28, 2015 · Completed: Jul 31, 2020
1 condition
1 sponsor
1 location
NCT02502396
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
N/A
Completed
265 participants
Started: Sep 28, 2015 · Completed: Mar 15, 2022
4 conditions
2 sponsors
1 location
NCT02565420
Saline Versus Lactated Ringer's Solution: The SOLAR Fluid Trial
NA
Completed
8,616 participants
Started: Sep 28, 2015 · Completed: Jan 31, 2019
1 condition
1 sponsor
1 location
NCT02489526
Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery
PHASE2
Completed
60 participants
Started: Sep 28, 2015 · Completed: Aug 15, 2016
1 condition
1 sponsor
3 locations
NCT02554019
Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus
PHASE2
Completed
36 participants
Started: Sep 28, 2015 · Completed: Oct 25, 2017
1 condition
1 sponsor
14 locations
NCT03037749
Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
EARLY_PHASE1
Completed
42 participants
Started: Sep 27, 2015 · Completed: Aug 31, 2018
2 conditions
2 sponsors
1 location
NCT02284035
Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine
PHASE3
Completed
75 participants
Started: Sep 27, 2015 · Completed: Feb 28, 2017
1 condition
1 sponsor
1 location
NCT02304432
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
EARLY_PHASE1
Completed
2 participants
Started: Sep 27, 2015 · Completed: Jul 31, 2017
2 conditions
2 sponsors
0 locations
NCT03097991
Randomized Controlled Trial of Prenatal Coparenting Intervention (CoparentRCT)
NA
Completed
276 participants
Started: Sep 26, 2015 · Completed: Dec 18, 2021
1 condition
2 sponsors
1 location
NCT02779270
Test the Outdoor Usage for Sunscreen Products in Female Adults
NA
Completed
105 participants
Started: Sep 26, 2015 · Completed: Sep 27, 2015
1 condition
1 sponsor
1 location
NCT02267161
Infants With Agenesis of the Corpus Callosum
NA
Completed
72 participants
Started: Sep 26, 2015 · Completed: Jan 11, 2022
1 condition
1 sponsor
1 location
NCT03850275
The Effects of e+Shots Energy Beverage on Mental Energy
NA
Completed
30 participants
Started: Sep 26, 2015 · Completed: Dec 15, 2016
1 condition
2 sponsors
0 locations
Previous
1
More pages
2910
2911
2912
2913
2914
2915
2916
More pages
6093
Next